Celprogen是一家生物技术公司，为心脏病学、肿瘤学、糖尿病和神经病学的再生医学研发干细胞研究和治疗产品。Celprogen的所有生物产品，包括干细胞、癌症干细胞、IPC和包括ECM在内的培养基，均在美国制造和生产。

CELPROGEN is a biotechnology company developing stem cell research and therapeutics products for regenerative medicine in cardiology, oncology, diabetes & neurology. All of Celprogen’s biological products, including stem cells, cancer stem cells, iPC’s & media including ECM’s, are manufactured and produced in the United States of America. CELPROGEN provides novel molecular diagnostics and therapeutic product development solutions for Biotechnology, Pharmaceutical, Invitro diagnostics and academic partnership for drug discovery.

Celprogen公司的主要产品：

3D Culture Systems

Biological Reagents

Cell-Based Assay Kits

Cosmetic

Devices

ExtracellularMatrix

Human Serum Albumin (HSA)

Life Science

Normal Cells

Organ Cultures

Patient-Derived Xenografts [PDX]

Therapeutics

Tumorgenicity

Vaccine Development

Xeno-Free Media

Mediomics公司2001年成立，致力于为学术机构、制药公司、医学研究者、环境研究者提供创新性的检测试剂盒及生物感应物质。Mediomics拥有Patented Bridge-It® Assay Platform、Patented FRET-PINCER® Assay Platform、Patented TRF-PINCER® Assay Platform三大技术平台。

Mediomics, LLC provides innovative assay kits and biosensors needed by academic research laboratories, point of care testing, pharmaceutical companies, as well as medical and environmental research markets.  

Technology platforms:

（1）Patented Bridge-It® Assay Platform

Bridge-It® Assays are optimized to measure DNA binding proteins, their ligands, and co-regulators. Mediomics’ Bridge-It® assay was based on a simple idea of splitting the DNA binding site for a protein into two DNA half-sites. The presence of the DNA-binding protein or one of its ligands can be detected by FRET (fluorescence resonance energy transfer).

（2）Patented FRET-PINCER® Assay Platform

FRET-PINCER® Assays are a unique system to quantify the concentration of biomarkers, cells, and pathogens in a broad range of biological samples. The patent-protected FRET-PINCER® Assay system detects the concentration of the target molecule by bringing together complementary single-stranded DNAs and their attached fluorophores to produce fluorescent light through FRET (fluorescence resonance energy transfer).

（3）Patented TRF-PINCER® Assay Platform

TRF-PINCER® Assays are a unique system to quantify the concentration of biomarkers, cells, and pathogens in a broad range of biological samples. The patent-protected TRF-PINCER® Assay platform system detects the concentration of the target molecule by bringing together complementary single-stranded DNAs and their attached fluorophores to produce fluorescent light with Time-Resolved Fluorometry (TRF) sensitivity.

主要产品线包括：

（1）Bridge-It® Assay

（2）TR-FRET Bridge-It® Assay

（3）FRET-PINCER® Assay

（4）TR-FRET PINCER®Assay

（5）Other

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Novocib品牌全系列产品

Novocib是一家成立于2005年的生物技术公司，专注于核苷酸代谢领域。公司开发了一系列用于细胞、食品和饲料原料中核苷酸分析的创新产品与服务，包括：全谱核苷酸分析服务、核苷酸酶检测试剂盒，核苷酸代谢纯化活性酶以及富含核苷酸的新产品和原料开发协助。

▍Novocib产品线

● 核苷酸分析：

包含全谱核苷酸分析，其涵盖杂环碱基、核苷、核苷酸以及核酸（DNA 和 RNA）；酵母提取物中核苷、5'-核苷酸及核酸分析以及食品或饲料原料中嘌呤，嘧啶分析。

● PRECICE®一步法试剂盒：

预置精确定量的酶、缓冲液、辅因子及底物，浓度均为最佳配比；采用 96 孔微孔板规格；便捷省时，避免潜在操作误差。

● 活性纯化酶制剂：

核苷激酶；嘌呤代谢酶；支持微量至批量订购